About Samuel

Sam joins FPC from Eradigm Consulting, a boutique life sciences consultancy. As a project manager there, he led market, competitive and opportunity assessments of emerging assets for global pharma and biotech clients. Those projects informed their investment and portfolio decisions.

Before that, Sam did a PhD with AstraZeneca on optimising mRNA vaccine technology, and he also worked part-time at the TechBio VC fund Next Sequence.